Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies
2016 · Nature Communications · 142 citations
https://doi.org/10.1038/ncomms13818
S
Serena Mazzucchelli
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
155
Papers
3.2K
Citations
35
h-index
71
i10-index
Serena Mazzucchelli is an academic researcher from University of Milan. The author has contributed to research in topics: Nanoparticle-Based Drug Delivery & Monoclonal and Polyclonal Antibodies Research & Advanced biosensing and bioanalysis techniques. The author has an h-index of 35, co-authored 132 publications.
ORCID: 0000-0001-6904-8895Papers by this author
worksHER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment
2022 · Cancers · 86 citations
https://doi.org/10.3390/cancers14102424
HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches
2010 · Pharmacological Research · 73 citations
https://doi.org/10.1016/j.phrs.2010.01.013
Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells
2018 · Scientific Reports · 71 citations
https://doi.org/10.1038/s41598-018-24968-x
HER2 Expression in Breast Cancer Cells Is Downregulated Upon Active Targeting by Antibody-Engineered Multifunctional Nanoparticles in Mice
2011 · ACS Nano · 67 citations
https://doi.org/10.1021/nn201570n
H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer
2017 · Scientific Reports · 66 citations
https://doi.org/10.1038/s41598-017-07617-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat